232 related articles for article (PubMed ID: 35345264)
1. Interleukin Receptor Associated Kinase 1 Signaling and Its Association with Cardiovascular Diseases.
Zheng Y; He JQ
Rev Cardiovasc Med; 2022 Mar; 23(3):97. PubMed ID: 35345264
[TBL] [Abstract][Full Text] [Related]
2. IRAK family in inflammatory autoimmune diseases.
Su LC; Xu WD; Huang AF
Autoimmun Rev; 2020 Mar; 19(3):102461. PubMed ID: 31917263
[TBL] [Abstract][Full Text] [Related]
3. Inherited human IRAK-1 deficiency selectively impairs TLR signaling in fibroblasts.
Della Mina E; Borghesi A; Zhou H; Bougarn S; Boughorbel S; Israel L; Meloni I; Chrabieh M; Ling Y; Itan Y; Renieri A; Mazzucchelli I; Basso S; Pavone P; Falsaperla R; Ciccone R; Cerbo RM; Stronati M; Picard C; Zuffardi O; Abel L; Chaussabel D; Marr N; Li X; Casanova JL; Puel A
Proc Natl Acad Sci U S A; 2017 Jan; 114(4):E514-E523. PubMed ID: 28069966
[TBL] [Abstract][Full Text] [Related]
4. A noncanonical IRAK4-IRAK1 pathway counters DNA damage-induced apoptosis independently of TLR/IL-1R signaling.
Li Y; Shah RB; Sarti S; Belcher AL; Lee BJ; Gorbatenko A; Nemati F; Yu H; Stanley Z; Rahman M; Shao Z; Silva JM; Zha S; Sidi S
Sci Signal; 2023 Dec; 16(816):eadh3449. PubMed ID: 38113335
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 1/Toll-like receptor-induced autophosphorylation activates interleukin 1 receptor-associated kinase 4 and controls cytokine induction in a cell type-specific manner.
Cushing L; Stochaj W; Siegel M; Czerwinski R; Dower K; Wright Q; Hirschfield M; Casanova JL; Picard C; Puel A; Lin LL; Rao VR
J Biol Chem; 2014 Apr; 289(15):10865-10875. PubMed ID: 24567333
[TBL] [Abstract][Full Text] [Related]
6. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family.
Martin MU; Wesche H
Biochim Biophys Acta; 2002 Nov; 1592(3):265-80. PubMed ID: 12421671
[TBL] [Abstract][Full Text] [Related]
7. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4.
Suzuki N; Suzuki S; Duncan GS; Millar DG; Wada T; Mirtsos C; Takada H; Wakeham A; Itie A; Li S; Penninger JM; Wesche H; Ohashi PS; Mak TW; Yeh WC
Nature; 2002 Apr; 416(6882):750-6. PubMed ID: 11923871
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4.
Burns K; Janssens S; Brissoni B; Olivos N; Beyaert R; Tschopp J
J Exp Med; 2003 Jan; 197(2):263-8. PubMed ID: 12538665
[TBL] [Abstract][Full Text] [Related]
9. Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-kappaB activation.
Conze DB; Wu CJ; Thomas JA; Landstrom A; Ashwell JD
Mol Cell Biol; 2008 May; 28(10):3538-47. PubMed ID: 18347055
[TBL] [Abstract][Full Text] [Related]
10. A novel splice variant of interleukin-1 receptor (IL-1R)-associated kinase 1 plays a negative regulatory role in Toll/IL-1R-induced inflammatory signaling.
Rao N; Nguyen S; Ngo K; Fung-Leung WP
Mol Cell Biol; 2005 Aug; 25(15):6521-32. PubMed ID: 16024789
[TBL] [Abstract][Full Text] [Related]
11. IL-1 receptor-associated kinase 4 is essential for IL-18-mediated NK and Th1 cell responses.
Suzuki N; Chen NJ; Millar DG; Suzuki S; Horacek T; Hara H; Bouchard D; Nakanishi K; Penninger JM; Ohashi PS; Yeh WC
J Immunol; 2003 Apr; 170(8):4031-5. PubMed ID: 12682231
[TBL] [Abstract][Full Text] [Related]
12. Cutting edge: TLR signaling licenses IRAK1 for rapid activation of the NLRP3 inflammasome.
Fernandes-Alnemri T; Kang S; Anderson C; Sagara J; Fitzgerald KA; Alnemri ES
J Immunol; 2013 Oct; 191(8):3995-9. PubMed ID: 24043892
[TBL] [Abstract][Full Text] [Related]
13. IL-1 receptor-associated kinase 1 mediates protection against Staphylococcus aureus infection.
Verdrengh M; Thomas JA; Hultgren OH
Microbes Infect; 2004 Nov; 6(14):1268-72. PubMed ID: 15555532
[TBL] [Abstract][Full Text] [Related]
14. IRAK-4 kinase activity is required for interleukin-1 (IL-1) receptor- and toll-like receptor 7-mediated signaling and gene expression.
Koziczak-Holbro M; Joyce C; Glück A; Kinzel B; Müller M; Tschopp C; Mathison JC; Davis CN; Gram H
J Biol Chem; 2007 May; 282(18):13552-60. PubMed ID: 17337443
[TBL] [Abstract][Full Text] [Related]
15. The recent advance of Interleukin-1 receptor associated kinase 4 inhibitors for the treatment of inflammation and related diseases.
Bai YR; Yang WG; Hou XH; Shen DD; Zhang SN; Li Y; Qiao YY; Wang SQ; Yuan S; Liu HM
Eur J Med Chem; 2023 Oct; 258():115606. PubMed ID: 37402343
[TBL] [Abstract][Full Text] [Related]
16. The interleukin-1 receptor-associated kinases: critical regulators of innate immune signalling.
Flannery S; Bowie AG
Biochem Pharmacol; 2010 Dec; 80(12):1981-91. PubMed ID: 20599782
[TBL] [Abstract][Full Text] [Related]
17. IRAK-4 as the central TIR signaling mediator in innate immunity.
Suzuki N; Suzuki S; Yeh WC
Trends Immunol; 2002 Oct; 23(10):503-6. PubMed ID: 12297423
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a dual role in myddosome formation and Toll-like receptor signaling.
De Nardo D; Balka KR; Cardona Gloria Y; Rao VR; Latz E; Masters SL
J Biol Chem; 2018 Sep; 293(39):15195-15207. PubMed ID: 30076215
[TBL] [Abstract][Full Text] [Related]
19. Pellino proteins are more than scaffold proteins in TLR/IL-1R signalling: a role as novel RING E3-ubiquitin-ligases.
Schauvliege R; Janssens S; Beyaert R
FEBS Lett; 2006 Aug; 580(19):4697-702. PubMed ID: 16884718
[TBL] [Abstract][Full Text] [Related]
20.
Parmar N; Chandrakar P; Vishwakarma P; Singh K; Mitra K; Kar S
J Immunol; 2018 Aug; 201(3):957-970. PubMed ID: 29907707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
